Skip NavigationSkip to Content

Genome-scale exon perturbation screens uncover exons critical for cell fitness

  1. Author:
    Xiao,Meisheng
    Damodaran,Arun Prasath
    Kumari,Bandana
    Dickson, Ethan
    Xing, Kun
    On, Tyler A
    Parab, Nikhil
    King, Helen E
    Perez, Alexendar R
    Guiblet,Wilfried
    Duncan,Gerard
    Che,Anney
    Chari,Raj
    Andresson,Thorkell
    Vidigal, Joana A
    Weatheritt, Robert J
    Aregger,Michael
    Gonatopoulos Pournatzis,Thomas
  2. Author Address

    RNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA., RNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA. Electronic address: arunprasath.damodaran@nih.gov., Molecular Targets Program, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA., EMBL Australia and Garvan Institute of Medical Research, Sydney, NSW 2010, Australia., Laboratory of Biochemistry and Molecular Biology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA; Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA 94143, USA., Protein Characterization Laboratory, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD 21701, USA., Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD 21701, USA., Genome Modification Core, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD 21702, USA., Laboratory of Biochemistry and Molecular Biology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., EMBL Australia and Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2010, Australia., Molecular Targets Program, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA. Electronic address: michael.aregger@nih.gov., RNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA. Electronic address: thomas.gonatopoulos@nih.gov.,
    1. Year: 2024
    2. Date: Jul 11
    3. Epub Date: 2024 06 18
  1. Journal: Molecular Cell
    1. 84
    2. 13
    3. Pages: 2553-2572
  2. Type of Article: Article
  1. Abstract:

    CRISPR-Cas technology has transformed functional genomics, yet understanding of how individual exons differentially shape cellular phenotypes remains limited. Here, we optimized and conducted massively parallel exon deletion and splice-site mutation screens in human cell lines to identify exons that regulate cellular fitness. Fitness-promoting exons are prevalent in essential and highly expressed genes and commonly overlap with protein domains and interaction interfaces. Conversely, fitness-suppressing exons are enriched in nonessential genes, exhibiting lower inclusion levels, and overlap with intrinsically disordered regions and disease-associated mutations. In-depth mechanistic investigation of the screen-hit TAF5 alternative exon-8 revealed that its inclusion is required for assembly of the TFIID general transcription initiation complex, thereby regulating global gene expression output. Collectively, our orthogonal exon perturbation screens established a comprehensive repository of phenotypically important exons and uncovered regulatory mechanisms governing cellular fitness and gene expression. Published by Elsevier Inc.

    See More

External Sources

  1. DOI: 10.1016/j.molcel.2024.05.024
  2. PMID: 38917794
  3. PMCID: PMC11246229
  4. WOS: 001269381900001
  5. PII : S1097-2765(24)00447-7

Library Notes

  1. Fiscal Year: FY2023-2024
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel